Acadia
is a California-based biopharmaceutical company that discovers and develops novel therapies for the treatment of Parkinson’s disease... Read moreAcadia
is a California-based biopharmaceutical company that discovers and develops novel therapies for the treatment of Parkinson’s disease... Read more
News
Feb 11, 2026
Americanbankingnews
Acadia: Candriam S.C.A. Boosts Stake in UL Solutions Inc. $ULS
Feb 03, 2026
Benzinga
Acadia: EU Panel Rejects Acadia Pharmaceuticals Rett Syndrome Drug
Jan 14, 2026
Finance News Network
Acadia: Acadia Foresees Daybue Sales Surge by 2028
Jan 13, 2026
BioSpace
Acadia: Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech
Dec 18, 2025
Marketscreener
Acadia: Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
Dec 06, 2025
Yahoo
Acadia: Assessing ACADIA Pharmaceuticals Valuation After Strong 2024 Share Price Rally
Dec 04, 2025
Nasdaq
Acadia: Acadia Stock Up 59% in a Year - Is a $51 Million New Stake a Bet on a Bigger Rebound?
Dec 04, 2025
Seeking Alpha
Acadia: Buy Acadia Pharmaceuticals For Daybue/Nuplazid Stability And Pipeline Optionality
Dec 03, 2025
Yahoo
Acadia: Acadia to pivot to Alzheimer's psychosis pipeline, accd to Wall Street analysts
Nov 06, 2025
Seeking Alpha
Acadia: ACADIA Pharmaceuticals Inc. 2025 Q3 - Results - Earnings Call Presentation
